Daito Pharmaceutical Co., Ltd.

¥1,304As of Sun 8 Nov 2026, 12:00 UTC
TSE:4577Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 4.27%
Div yield 3.45%
ROE 6.07%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.14
PE TTM 11.96
TSR TTM 8.23%
Mkt cap ¥36.85B
ROIC 4.45%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥1,378
5.69%
35.64%
Hold 5|7|8|3|6
2Q26
3Q26
4Q26
1Q27
Earnings per share¥
15.66
15.49
16.71
16.15
10.62%
4.78%
5.20%
(0.86%)
Revenue¥B
4.391
4.477
4.348
4.294
15.74%
15.17%
9.59%
3.10%
Peers (US$234.0M)
Cap (US$)
PE
294.9M
14.89x
202.2M
9.870x
236.0M
6.126x
Capital
TTM
5Y
10Y
Leveragex
0.430
0.223
0.230
EBIT/Intx
0.186
1.431
1.387
Own earn%
(32.61)
105.21
87.13
Sh yield%
47.16
14.82
15.89
Owners
Insiders/Inst%
14.76
45.10
Short interest%
2.14
SBC / revenue%
4.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
20–26
$1 testx
—
Incr. ROIC%
1